ICOW - ETF AI Analysis
Top Page
Pacer Developed Markets International Cash Cows 100 ETF (ICOW)
Rating:63Neutral
Price Target:―
Positive Factors
Broad International Diversification
The fund spreads its investments across many developed countries, which helps reduce the impact of problems in any single market.
Mix of Different Sectors
Holdings are spread across industries like industrials, materials, consumer companies, energy, and health care, which can help smooth out returns when one sector struggles.
Several Strong Top Holdings
Some of the largest positions, such as Prysmian, Sumitomo, DHL Group, and CK Hutchison, have shown strong recent performance, supporting the ETF’s overall results.
Negative Factors
Relatively High Expense Ratio
The fund’s expense ratio is on the higher side for an ETF, which means more of your returns go toward fees each year.
Recent Short-Term Weakness
The ETF has experienced a recent short-term pullback, as shown by its weak one-month performance.
Top Holdings Include Some Weak Performers
A few major positions, such as KDDI, Agnico Eagle, Barrick Mining, and Ahold Delhaize, have lagged recently, which can drag on the fund’s overall performance.
ICOW vs. SPDR S&P 500 ETF (SPY)
AUM1.76B
RegionDeveloped Markets
Expense Ratio0.65%
Beta0.64
IssuerPacer
Inception DateJun 16, 2017
Dividend Yield2.31%
Asset ClassEquity
Index TrackedPacer Developed Markets International Cash Cows 100 Index
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. Volume188,229
30 Day Avg. Volume199,285
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
48.50Price Target Upside― Downside
Rating ConsensusModerate Buy
Number of Analyst Covering100
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
ICOW Summary
ICOW is the Pacer Developed Markets International Cash Cows 100 ETF, which follows the Pacer Developed Markets International Cash Cows 100 Index. It invests in 100 companies from developed countries outside the U.S. that generate strong free cash flow, meaning they tend to bring in more cash than they spend. The fund holds well-known names like DHL Group and Takeda Pharmaceutical. Someone might invest in ICOW to diversify beyond the U.S. and add financially solid international companies to their portfolio. A key risk is that international stock prices can go up and down with global markets and currency swings.
How much will it cost me?The expense ratio for the Pacer Developed Markets International Cash Cows 100 ETF (ICOW) is 0.65%, which means you’ll pay $6.50 per year for every $1,000 invested. This is higher than average because the fund is actively managed, focusing on selecting cash-rich companies in developed international markets.
What would affect this ETF?ICOW's focus on cash-rich companies in developed markets could benefit from global economic stability and growth in sectors like Energy and Industrials, which have significant weight in the ETF. However, it may face challenges if international regulations tighten or if economic conditions in key regions like Europe or Japan weaken, impacting top holdings such as Mitsubishi and Glencore. Additionally, fluctuations in commodity prices or geopolitical tensions could influence the performance of companies in sectors like Materials and Energy.
ICOW Top 10 Holdings
ICOW leans into a global mix of cash-rich names outside the U.S., with Europe and Japan doing much of the heavy lifting. Industrial and infrastructure players like Prysmian and Vinci are quietly powering the fund, while DHL’s steady uptrend adds a reliable tailwind. On the flip side, gold miners Agnico Eagle and Barrick are losing altitude, and Ahold Delhaize has been a noticeable drag. Japanese giants like Sumitomo and KDDI show mixed signals, leaving the ETF diversified but still driven by a handful of industrial and materials workhorses.
Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| Takeda Pharmaceutical Co | 2.25% | $39.55M | ¥8.86T | 16.96% | 66 Neutral | |
| DHL Group | 2.21% | $38.81M | €63.89B | 40.50% | 76 Outperform | |
| KDDI | 2.18% | $38.34M | ¥10.36T | 21.72% | 76 Outperform | |
| CK Hutchison Holdings | 2.14% | $37.56M | HK$273.66B | 35.27% | 64 Neutral | |
| Vodafone | 2.12% | $37.23M | £26.88B | 40.39% | 63 Neutral | |
| Suncor Energy | 2.09% | $36.70M | $76.53B | 67.28% | 77 Outperform | |
| Shell (UK) | 2.06% | $36.21M | £182.42B | 24.06% | 73 Outperform | |
| Koninklijke Ahold Delhaize N.V. | 2.00% | $35.13M | €31.27B | -3.36% | 62 Neutral | |
| Sanofi | 1.99% | $34.89M | €92.66B | -12.22% | 75 Outperform | |
| BP p.l.c. | 1.98% | $34.85M | £83.33B | 33.31% | 71 Outperform |
ICOW Technical Analysis
Negative
―
Price Trends
43.41
Negative
43.14
Negative
41.04
Positive
Market Momentum
-0.12
Negative
47.39
Neutral
64.12
Neutral
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For ICOW, the sentiment is Negative. The current price of undefined is equal to the 20-day moving average (MA) of 42.25, equal to the 50-day MA of 43.41, and equal to the 200-day MA of 41.04, indicating a neutral trend. The MACD of -0.12 indicates Negative momentum. The RSI at 47.39 is Neutral, neither overbought nor oversold. The STOCH value of 64.12 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for ICOW.
ICOW Peer Comparison
Comparison Results
Performance Comparison
ICOW
Pacer Developed Markets International Cash Cows 100 ETF
42.50
8.18
23.83%
GSIE
Goldman Sachs ActiveBeta International Equity ETF
―
―
―
LVHI
Legg Mason International Low Volatility High Dividend ETF
―
―
―
IMTM
iShares MSCI Intl Momentum Factor ETF
―
―
―
IDMO
Invesco S&P International Developed Momentum ETF
―
―
―
INTF
iShares MSCI Intl Multifactor ETF
―
―
―
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
DisclaimerThis AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―
Table of Contents